tradingkey.logo
tradingkey.logo
Search

Longeveron announces constructive Type C meeting with U.S. FDA ahead of data readout for ELPIS II Phase 2b clinical trial evaluating treatment for Hypoplastic Left Heart Syndrome

ReutersMay 8, 2026 8:19 PM
facebooktwitterlinkedin
View all comments0
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Sign up for Tradingkey to unlock the full content

Free signup

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI